Advertisement

Topics

FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease

20:08 EDT 10 Aug 2018 | Drugs.com

August 10, 2018 -- The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who have a genetic mutation...

Original Article: FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...